PLOS Medicine - This week in #PLOSMedicine: iron during #pregnancy; MSM, assault, & #HIV in South Africa; & #malaria surveillance: http://t.co/GrGcaA3K66
PLOS Pathogens - RT @GSSHealth: Vitamin D Modulates Paracrine Signaling to Control M. #tuberculosis Infection http://t.co/dO06uWGAzx @PLoSPathogens #TB #inf…
PLOS NTDs - @mozilla, the folks that brought you Firefox, announce the Mozilla Science Lab initiative to foster open science.
http://t.co/ZXDpGYphsl
-
Image Credit: Alberto G. -
Recent Posts
- This Week in PLOS Medicine: Iron Supplements during Pregnancy; Male-Male Consensual Sex, Sexual Violence, & HIV in South Africa; & Malaria Surveillance
- Book Review: The Recession Hurt Many People, Now Austerity is Hurting More
- Restoring Invisible and Abandoned Trials: A Creative Approach to a Public Good; Now a Creative Approach to Implementation is Needed
- This Week in PLOS NTDs and PLOS Pathogens: Dams and Disease Triggers, Insights into Disease Transmission Models, African vs. Eurasian Leishmania Genus, P. vivax Vaccine Development, and More
- This Week in PLOS Medicine: Noncommunicable Disease Prevention in LMICs, Active Commutes in Urbanizing India, & Traffic Crashes as a Neglected Issue
- Why are we so afraid of vaccines?
Topics
Africa antimicrobial drugs antiretroviral treatment cardiovascular health child health china clinical trials developing world diarrhea environment Ghostwriting global burden of disease global health guidelines Haiti health costs health information health policy health systems HIV HIV/AIDS influenza LMICs malaria maternal and perinatal health maternal health medical literature medical students Mental Health mortality MSF neglected tropical diseases open access pharmaceutical industry Policy public health reporting research ethics sanitation sub-saharan Africa systematic reviews tuberculosis vaccine water WHO
Blog Archives
Drug Companies and Patient Groups: Uneasy Bedfellows
Category: General, Media
Tagged conflicts of interest, patient support groups, pharmaceutical industry
Comments Off
Mining the ghostwriting documents results in university investigation
Category: Ghostwriting, Media, Public
Tagged Canada, Ghostwriting, pharmaceutical industry
1 Comment
Ghostwriting documents now fully available on PLoS Medicine website
Category: Authors, Ghostwriting, Public
Tagged Ghostwriting, pharmaceutical industry, research ethics
11 Comments
HPV – the debate continues
Category: PLoS Medicine's Daily Click
Tagged health information, pharmaceutical industry, vaccine
1 Comment
Ghostwriting 101
Category: Authors, Ghostwriting, Public
Tagged Ghostwriting, medical literature, pharmaceutical industry
3 Comments
What should be done to tackle ghostwriting in medical literature?
Category: Authors, Ghostwriting, Media, Public
Tagged Ghostwriting, medical literature, pharmaceutical industry
4 Comments
PLoS Medicine and the New York Times victorious in court; Public will have access to ghostwriting documents
Category: Authors, Ghostwriting, Media, Public
Tagged Ghostwriting, medical literature, pharmaceutical industry
13 Comments
Successful intervention by PLoS Medicine and New York Times in Federal court grants public access to evidence that drug company ‘ghostwrote’ medical articles about hormone therapy drug, Prempro
Category: Authors, Ghostwriting, Public
Tagged Ghostwriting, medical literature, pharmaceutical industry
2 Comments